Register Now: Image-Based Risk: The Next Frontier in Breast Cancer Screening
|Articles|April 10, 1996

SMV's attenuation correction cleared

Nuclear medicine vendor SMV of Twinsburg, OH, has announced thatthe Food and Drug Administration has issued 510(k) clearance forits transmission attenuation correction (TAC) protocol. TAC isdesigned for SMV's Vision DST and Vision DST-XL

Nuclear medicine vendor SMV of Twinsburg, OH, has announced that

the Food and Drug Administration has issued 510(k) clearance for

its transmission attenuation correction (TAC) protocol. TAC is

designed for SMV's Vision DST and Vision DST-XL variable-angle

gamma cameras.


Related to this article

Emerging Research Insights and New Advances in Neuroradiology
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.